Go Pro
→ A letter from Shannon Stansberry (From Porter & Company) (Ad)tc pixel Free AREC Stock Alerts

Arecor Therapeutics (AREC) Competitors

Arecor Therapeutics logo
GBX 73.50 0.00 (0.00%)
As of 08/28/2026 12:34 PM Eastern
Compare

AREC vs. AURA, NEO, NCCL, ARMS, and BHR

Should you buy Arecor Therapeutics stock or one of its competitors? Arecor Therapeutics's main competitors and comparable companies include Aura Energy (AURA), Neo Energy Metals (NEO), Ncondezi Energy (NCCL), Asia Resource Minerals (ARMS), and Beacon Hill Resources (BHR). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "coal & consumable fuels" industry.

How does Arecor Therapeutics compare to Aura Energy?

Arecor Therapeutics (LON:AREC) and Aura Energy (LON:AURA) are both small-cap energy companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, valuation, analyst recommendations, earnings, media sentiment, institutional ownership, risk and dividends.

6.0% of Arecor Therapeutics shares are held by institutional investors. Comparatively, 12.5% of Aura Energy shares are held by institutional investors. 4.8% of Arecor Therapeutics shares are held by company insiders. Comparatively, 5.9% of Aura Energy shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Arecor Therapeutics' average media sentiment score of 0.00 equaled Aura Energy'saverage media sentiment score.

Company Overall Sentiment
Arecor Therapeutics Neutral
Aura Energy Neutral

Arecor Therapeutics has a beta of -0.18, suggesting that its stock price is 118% less volatile than the broader market. Comparatively, Aura Energy has a beta of -0.35, suggesting that its stock price is 135% less volatile than the broader market.

Arecor Therapeutics has a net margin of 38.74% compared to Aura Energy's net margin of 0.00%. Arecor Therapeutics' return on equity of 14.26% beat Aura Energy's return on equity.

Company Net Margins Return on Equity Return on Assets
Arecor Therapeutics38.74% 14.26% -37.31%
Aura Energy N/A -17.87%-8.03%

Aura Energy has lower revenue, but higher earnings than Arecor Therapeutics. Aura Energy is trading at a lower price-to-earnings ratio than Arecor Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Arecor Therapeutics£1.71M16.19-£10.68M£2.0036.75
Aura EnergyN/AN/A-£16.15K-£1.11N/A

Summary

Arecor Therapeutics beats Aura Energy on 6 of the 10 factors compared between the two stocks.

How does Arecor Therapeutics compare to Neo Energy Metals?

Arecor Therapeutics (LON:AREC) and Neo Energy Metals (LON:NEO) are both small-cap energy companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, media sentiment, profitability, dividends, analyst recommendations and valuation.

Arecor Therapeutics has a net margin of 38.74% compared to Neo Energy Metals' net margin of 0.00%. Arecor Therapeutics' return on equity of 14.26% beat Neo Energy Metals' return on equity.

Company Net Margins Return on Equity Return on Assets
Arecor Therapeutics38.74% 14.26% -37.31%
Neo Energy Metals N/A -503.60%N/A

6.0% of Arecor Therapeutics shares are owned by institutional investors. Comparatively, 3.5% of Neo Energy Metals shares are owned by institutional investors. 4.8% of Arecor Therapeutics shares are owned by insiders. Comparatively, 40.8% of Neo Energy Metals shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Neo Energy Metals has lower revenue, but higher earnings than Arecor Therapeutics. Neo Energy Metals is trading at a lower price-to-earnings ratio than Arecor Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Arecor Therapeutics£1.71M16.19-£10.68M£2.0036.75
Neo Energy MetalsN/AN/A-£4.24M£0.184.65

In the previous week, Arecor Therapeutics' average media sentiment score of 0.00 equaled Neo Energy Metals'average media sentiment score.

Company Overall Sentiment
Arecor Therapeutics Neutral
Neo Energy Metals Neutral

Arecor Therapeutics has a beta of -0.18, indicating that its share price is 118% less volatile than the broader market. Comparatively, Neo Energy Metals has a beta of 4.995, indicating that its share price is 400% more volatile than the broader market.

Summary

Arecor Therapeutics beats Neo Energy Metals on 6 of the 10 factors compared between the two stocks.

How does Arecor Therapeutics compare to Ncondezi Energy?

Ncondezi Energy (LON:NCCL) and Arecor Therapeutics (LON:AREC) are both small-cap energy companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, media sentiment, profitability, risk, institutional ownership and analyst recommendations.

9.7% of Ncondezi Energy shares are owned by institutional investors. Comparatively, 6.0% of Arecor Therapeutics shares are owned by institutional investors. 34.3% of Ncondezi Energy shares are owned by insiders. Comparatively, 4.8% of Arecor Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Ncondezi Energy has higher earnings, but lower revenue than Arecor Therapeutics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ncondezi EnergyN/AN/A-£2.05MN/AN/A
Arecor Therapeutics£1.71M16.19-£10.68M£2.0036.75

Ncondezi Energy has a beta of 1.05, indicating that its stock price is 5% more volatile than the broader market. Comparatively, Arecor Therapeutics has a beta of -0.18, indicating that its stock price is 118% less volatile than the broader market.

Arecor Therapeutics has a net margin of 38.74% compared to Ncondezi Energy's net margin of 0.00%. Arecor Therapeutics' return on equity of 14.26% beat Ncondezi Energy's return on equity.

Company Net Margins Return on Equity Return on Assets
Ncondezi EnergyN/A -15.23% -5.36%
Arecor Therapeutics 38.74%14.26%-37.31%

In the previous week, Ncondezi Energy's average media sentiment score of 0.00 equaled Arecor Therapeutics'average media sentiment score.

Company Overall Sentiment
Ncondezi Energy Neutral
Arecor Therapeutics Neutral

Summary

Ncondezi Energy beats Arecor Therapeutics on 5 of the 9 factors compared between the two stocks.

How does Arecor Therapeutics compare to Asia Resource Minerals?

Arecor Therapeutics (LON:AREC) and Asia Resource Minerals (LON:ARMS) are both energy companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, media sentiment, analyst recommendations, dividends, risk, valuation, earnings and institutional ownership.

In the previous week, Arecor Therapeutics' average media sentiment score of 0.00 equaled Asia Resource Minerals'average media sentiment score.

Company Overall Sentiment
Arecor Therapeutics Neutral
Asia Resource Minerals Neutral

Asia Resource Minerals has lower revenue, but higher earnings than Arecor Therapeutics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Arecor Therapeutics£1.71M16.19-£10.68M£2.0036.75
Asia Resource MineralsN/AN/AN/AN/AN/A

6.0% of Arecor Therapeutics shares are held by institutional investors. 4.8% of Arecor Therapeutics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Arecor Therapeutics has a net margin of 38.74% compared to Asia Resource Minerals' net margin of 0.00%. Arecor Therapeutics' return on equity of 14.26% beat Asia Resource Minerals' return on equity.

Company Net Margins Return on Equity Return on Assets
Arecor Therapeutics38.74% 14.26% -37.31%
Asia Resource Minerals N/A N/A N/A

Summary

Arecor Therapeutics beats Asia Resource Minerals on 5 of the 6 factors compared between the two stocks.

How does Arecor Therapeutics compare to Beacon Hill Resources?

Beacon Hill Resources (LON:BHR) and Arecor Therapeutics (LON:AREC) are both energy companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, dividends, media sentiment, valuation and analyst recommendations.

Arecor Therapeutics has a net margin of 38.74% compared to Beacon Hill Resources' net margin of 0.00%. Arecor Therapeutics' return on equity of 14.26% beat Beacon Hill Resources' return on equity.

Company Net Margins Return on Equity Return on Assets
Beacon Hill ResourcesN/A N/A N/A
Arecor Therapeutics 38.74%14.26%-37.31%

Beacon Hill Resources has higher earnings, but lower revenue than Arecor Therapeutics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Beacon Hill ResourcesN/AN/AN/AN/AN/A
Arecor Therapeutics£1.71M16.19-£10.68M£2.0036.75

6.0% of Arecor Therapeutics shares are held by institutional investors. 4.8% of Arecor Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, Beacon Hill Resources' average media sentiment score of 0.00 equaled Arecor Therapeutics'average media sentiment score.

Company Overall Sentiment
Beacon Hill Resources Neutral
Arecor Therapeutics Neutral

Summary

Arecor Therapeutics beats Beacon Hill Resources on 5 of the 6 factors compared between the two stocks.

Get Arecor Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for AREC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AREC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AREC vs. The Competition

Export
MetricArecor TherapeuticsOil, Gas & Consumable Fuels IndustryEnergy SectorLON Exchange
Market Cap£27.75M£11.27B£9.86B£2.90B
Dividend YieldN/A11.23%11.49%6.17%
P/E Ratio36.7518.5521.69367.35
Price / Sales16.19567.99465.5283,338.68
Price / Cash5.0739.5935.9827.89
Price / Book4.434.494.076.94
Net Income-£10.68M£5.27B£4.33B£5.89B
7 Day Performance9.70%1.04%1.12%0.39%
1 Month Performance19.51%5.54%5.26%3.36%
1 Year Performance16.13%34.50%36.28%22.34%

Arecor Therapeutics Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AREC
Arecor Therapeutics
N/AGBX 73.50
flat		N/A+16.4%£27.75M£1.71M36.7510
AURA
Aura Energy
N/AGBX 6.74
+7.8%		N/A-26.3%£68.66MN/AN/A50
NEO
Neo Energy Metals
N/AGBX 0.89
-1.4%		N/AN/A£24.77MN/A4.872,100
NCCL
Ncondezi Energy
N/AN/AN/AN/A£4.67MN/AN/A4
ARMS
Asia Resource Minerals
N/AN/AN/AN/A£0.00N/AN/A147,000

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:AREC) was last updated on 9/1/2026 by MarketBeat.com Staff.
From Our Partners
The end may be near for these iconic stocks
Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...
Chaikin Analytics | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
Buffett's Final Warning: "The Dollar Is Going to Hell"
On May 3rd, 2025, Warren Buffett looked at his shareholders for the last time and said: "The dollar is going t...
Decentralized Masters | Sponsoredtc pixel